Steward Partners Investment Advisory, LLC Amphastar Pharmaceuticals, Inc. Transaction History
Steward Partners Investment Advisory, LLC
- $9.37 Billion
- Q2 2024
A detailed history of Steward Partners Investment Advisory, LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 650 shares of AMPH stock, worth $32,357. This represents 0.0% of its overall portfolio holdings.
Number of Shares
650
Previous 250
160.0%
Holding current value
$32,357
Previous $10,000
160.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding AMPH
# of Institutions
279Shares Held
34.2MCall Options Held
25.5KPut Options Held
24.8K-
Black Rock Inc. New York, NY5.94MShares$296 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.67MShares$133 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.94MShares$96.8 Million0.19% of portfolio
-
Td Asset Management Inc1.69MShares$84.2 Million0.07% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$80.8 Million0.05% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $2.44B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...